Discover how the WHO's new guidelines on lenacapavir could revolutionise HIV prevention, offering a long-acting alternative ...

In recent months, reports of rising HIV infections in Malaysia have once again made national headlines. The data paints a ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

Integrating HIV and sexual health care is essential for improving outcomes, but global stigma, funding cuts—especially the defunding of USAID—and structural barriers like limited access and political ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as U.S.

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Most of the women who tested positive for the sexually transmitted disease were identified during Antenatal Clinics (ANC), alongside HIV.

IN Jamaica, many people still believe that if they feel fine, there’s no need to get tested for a sexually transmitted ...

Gugu used to collect her antiretrovirals from a USAID-funded clinic in central Johannesburg. But when President Trump's cuts to ...

Meningitis can be a frightening diagnosis. Our expert guide breaks down the different types—bacterial, viral, and fungal—and ...